Trial Profile
Use of Lisdexamfetamine Dimesylate In treatment of Cognitive Impairment and Fatigue: a Double-Blind, Placebo-Controlled Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Jul 2012
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Chronic fatigue syndrome
- Focus Therapeutic Use
- 10 Jul 2012 New trial record